Fatty liver disease (steatosis), with or without inflammation (steatohepatitis), is the most common liver disease with a rapid increase in recent decades. It is a manifestation of metabolic syndrome and is associated with increased morbidity and mortality.
In our clinic, the degree of fatty infiltration is measured using the innovative ATI (ATenuation Imaging) method, which is a fast, painless and bloodless method of quantitatively measuring fatty infiltration of the liver. This avoids the invasive biopsy, allowing for regular repetition and immediate control of the result and success of a treatment.